NCT06430983View on ClinicalTrials.gov

Recurrent Liver Cancer: Reconceptualization and Reevaluation

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

October 1, 2027

Conditions
Recurrent Liver CancerPrimary Liver Cancer
Trial Locations (1)

210000

RECRUITING

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER

NCT06430983 - Recurrent Liver Cancer: Reconceptualization and Reevaluation | Biotech Hunter | Biotech Hunter